Abstract

Liver and liver tumor segmentation provides vital biomarkers for surgical planning and hepatic diagnosis. In this paper, we propose and validate a novel level-set method integrating an enhanced edge indicator and an automatically derived initial curve for CT based liver tumor segmentation. At the preprocessing step, the CT image intensity values were truncated to lie in a fixed range to enhance the image contrast surrounding liver and liver tumor. To remove non-liver tissues for subsequent tumor segmentation, liver was firstly segmented using two convolutional neural networks in a coarse-to-fine manner. A 2D slice-based U-net was used to roughly localize the liver and a 3D patch-based fully convolutional network was used to refine the liver segmentation as well as to roughly localize the liver tumor. A novel level-set method was then presented to further refine the tumor segmentation. Specifically, the probabilistic distribution of the liver tumor was estimated using unsupervised fuzzy c-means clustering, which was then utilized to enhance the edge-detector used in level-set. Effectiveness of the proposed pipeline was validated on two publicly-available datasets. Experimental results identified the superior segmentation performance of the proposed pipeline over state-of-the-art methods.

Highlights

  • Liver is the largest gland in the human body and it is one of the most important metabolic organs of human being with multiple functions, such as metabolism, digestion and detoxification [1]

  • EXPERIMENTS AND RESULTS Below, section IV-A and section IV-B summarize results obtained from the ISICDM dataset and section IV-C presents results obtained from the Liver Tumor Segmentation (LiTS) dataset

  • The average DSC of the fine liver segmentation is 96.31%, which is significantly higher than that obtained from the coarse stage (p < 0.01)

Read more

Summary

Introduction

Liver is the largest gland in the human body (approximately 1500 grams) and it is one of the most important metabolic organs of human being with multiple functions, such as metabolism, digestion and detoxification [1]. Liver is vulnerable to many diseases such as hepatic steatosis and hepatitis which are leading causes of hepatic sclerosis and liver tumor. With approximately 841, 080 cases and 781, 631 attributed deaths reported globally in 2018 [2], liver tumor is one of the leading causes of cancer-related deaths. To ablate tumor tissues and leave the surrounding healthy tissues intact, there is. A need for accurately targeting the tumor area [3]. Computed tomography (CT) is one of the most widely used imaging modalities for liver tumor evaluation and staging [4]. Liver and liver tumor segmentations are obtained from experienced radiologists via manual delineation. An increased use of intraoperative 3D visualization systems underscores the urgency for automated liver and liver tumor segmentation [5]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call